AAAAAA
Results: 26-50/71
Authors:
HENRY M
MURPHY K
CALLAGHAN N
MITCHELL TH
Citation: M. Henry et al., DIABETIC NEUROPATHY AND DOPAMINE-BETA-HYDROXYLASE, Journal of drug development and clinical practice, 8(1), 1996, pp. 47-48
Authors:
CLARK JE
CLUNIE E
Citation: Je. Clark et E. Clunie, SECONDARY MANIA OCCURRING TWICE IN AN ELDERLY PATIENT FOLLOWING SURGERY CARRIED OUT UNDER LOCAL-ANESTHESIA, Journal of drug development and clinical practice, 8(1), 1996, pp. 49-52
Authors:
JAGROOP IA
MIKHAILIDIS DP
Citation: Ia. Jagroop et Dp. Mikhailidis, UNTITLED, Journal of drug development and clinical practice, 8(1), 1996, pp. 53-54
Authors:
FREEMAN HL
Citation: Hl. Freeman, SEROTONIN AND SCHIZOPHRENIA, Journal of drug development and clinical practice, 7(4), 1996, pp. 253-255
Authors:
ARYA DK
Citation: Dk. Arya, IS THE 5-HYDROXYTRYPTAMINE (5-HT) NEUROTRANSMITTER SYSTEM INVOLVED INREGULATION OF EXTRAPYRAMIDAL SYMPTOMS, Journal of drug development and clinical practice, 7(4), 1996, pp. 257-267
Authors:
EBERHARD G
Citation: G. Eberhard, THE EXTRAPYRAMIDAL SYMPTOMS RATING-SCALE (ESRS) AND ITS USE IN THE EVALUATION OF RISPERIDONE, Journal of drug development and clinical practice, 7(4), 1996, pp. 269-279
Authors:
LINDSTROM E
Citation: E. Lindstrom, THE HIDDEN COST OF SCHIZOPHRENIA, Journal of drug development and clinical practice, 7(4), 1996, pp. 281-288
Authors:
FREEMAN HL
Citation: Hl. Freeman, DRUG DEVELOPMENT REPORT .12. IS THERE A NEED FOR A PURE HYPNOTIC - APPROACHES TO THE CO-DIAGNOSIS OF INSOMNIA AND ANXIETY, Journal of drug development and clinical practice, 7(4), 1996, pp. 289-302
Authors:
PATERNA S
DIPASQUALE P
ANTONA A
CANNOVO A
BUCCA V
DAMICO C
PALAZZOADRIANO M
LICATA G
Citation: S. Paterna et al., EFFECTS OF FELODIPINE ON ISOLATED FAILING RAT-HEART, Journal of drug development and clinical practice, 7(4), 1996, pp. 303-307
Authors:
JEREMY JY
BRYAN AJ
ANGELINI GD
Citation: Jy. Jeremy et al., CHALLENGES IN DRUG RESEARCH - PATHOPHYSIOLOGY AND TREATMENT OF SAPHENOUS-VEIN GRAFT FAILURE, Journal of drug development and clinical practice, 7(4), 1996, pp. 309-312
Authors:
BURGER DM
MEENHORST PL
BULT A
BEIJNEN JH
Citation: Dm. Burger et al., LABORATORY TECHNIQUES IN DRUG DEVELOPMENT .5. EVALUATION OF 2 IMMUNOASSAYS FOR THE DETERMINATION OF ZIDOVUDINE IN BIOLOGICAL MATRICES, Journal of drug development and clinical practice, 7(4), 1996, pp. 313-318
Authors:
KAIJSER GP
BEIJNEN JH
KEIZER HJ
DEKRAKER J
BULT A
UNDERBERG WJM
Citation: Gp. Kaijser et al., LABORATORY TECHNIQUES IN DRUG DEVELOPMENT .6. PHARMACOKINETICS OF THEENANTIOMERS OF IFOSFAMIDE, 2-DECHLOROETHYLIFOSFAMIDE AND 3-DECHLOROETHYLIFOSFAMIDE IN PLASMA, URINE AND CEREBROSPINAL-FLUID, Journal of drug development and clinical practice, 7(4), 1996, pp. 319-326
Authors:
ZDEBSKI Z
GRYGLEWSKI RJ
RYTLEWSKI K
KOSTKATRABKA E
Citation: Z. Zdebski et al., L-ARGININE IN PREGNANCY COMPLICATED BY HYPERTENSION - A PRELIMINARY-REPORT, Journal of drug development and clinical practice, 7(4), 1996, pp. 327-330
Authors:
ELISAF M
MIKHAILIDIS DP
SIAMOPOULOS KC
Citation: M. Elisaf et al., DYSLIPIDEMIA IN PATIENTS WITH RENAL DISEASES, Journal of drug development and clinical practice, 7(4), 1996, pp. 331-348
Authors:
JONES A
Citation: A. Jones, NEOADJUVANT CHEMOTHERAPY, Journal of drug development and clinical practice, 7(3), 1995, pp. 137-139
Authors:
KHAYAT D
Citation: D. Khayat, WHAT IS THE ROLE OF VINDESINE IN NEOADJUVANT CHEMOTHERAPY, Journal of drug development and clinical practice, 7(3), 1995, pp. 141-150
Authors:
COIFFIER B
Citation: B. Coiffier, SHOULD VINDESINE BE USED IN STANDARD CHEMOTHERAPY REGIMENS FOR LYMPHOMA, Journal of drug development and clinical practice, 7(3), 1995, pp. 151-158
Authors:
RETSAS S
Citation: S. Retsas, STRATEGIES FOR IMPROVING SURVIVAL IN MALIGNANT-MELANOMA - FOCUS ON VINDESINE, Journal of drug development and clinical practice, 7(3), 1995, pp. 159-171
Authors:
PUIG LG
SANTAELLA RA
APARICIO PG
MORENO MR
DEROJAS FD
LAPUERTA JB
SAEZ LR
LOPEZ JDL
ALVAREZ JP
Citation: Lg. Puig et al., HEALING OF GASTRIC OR PRE-PYLORIC ULCERS WITH ONCE-DAILY OMEPRAZOLE 20MG OR RANITIDINE 300MG, Journal of drug development and clinical practice, 7(3), 1995, pp. 173-180
Authors:
BIRD HA
HILL J
STRATFORD ME
FENN GC
WRIGHT V
Citation: Ha. Bird et al., A DOUBLE-BLIND CROSS-OVER STUDY COMPARING THE ANALGESIC EFFICACY OF TRAMADOL WITH PENTAZOCINE IN PATIENTS WITH OSTEOARTHRITIS, Journal of drug development and clinical practice, 7(3), 1995, pp. 181-188
Authors:
ROBERTS E
BRADBROOK ID
IVERSEN PW
COHEN ML
Citation: E. Roberts et al., INHIBITION OF THE SEROTONERGIC COMPONENT OF HUMAN PLATELET-AGGREGATION FOLLOWING INTRAVENOUS ADMINISTRATION OF LY215840, A 5-HT2A RECEPTOR ANTAGONIST, Journal of drug development and clinical practice, 7(3), 1995, pp. 189-198
Authors:
DIMARZO V
DEPETROCELLIS L
BISOGNO T
MAURELLI S
Citation: V. Dimarzo et al., PHARMACOLOGY AND PHYSIOLOGY OF THE ENDOGENOUS CANNABIMIMETIC MEDIATORANANDAMIDE, Journal of drug development and clinical practice, 7(3), 1995, pp. 199-219
Authors:
UKERUN SO
Citation: So. Ukerun, LABORATORY TECHNIQUES IN DRUG DEVELOPMENT .4. SYNTHON GENERATION IN SYNTHESIS - THE PENICILLINS, Journal of drug development and clinical practice, 7(3), 1995, pp. 221-223
Authors:
BENNETT MR
Citation: Mr. Bennett, THE USE OF ANTISENSE OLIGONUCLEOTIDES AS THERAPEUTIC AGENTS - A REVIEW, Journal of drug development and clinical practice, 7(3), 1995, pp. 225-235
Authors:
HAUT FA
Citation: Fa. Haut, CLOZAPINE AND CHEMOTHERAPY, Journal of drug development and clinical practice, 7(3), 1995, pp. 237-239